| Authors: |
Robinson OC; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK o.c.robinson@leeds.ac.uk., Day F; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Boland EG; Palliative Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK., Collinson M; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Fallon M; Cancer Research Centre, The University of Edinburgh MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK., Farrin A; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Flemming K; Department of Health Sciences, University of York, York, UK., Girvan S; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Hartup S; St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Meads D; Academic Unit of Health Economics, University of Leeds Leeds Institute of Health Sciences, Leeds, UK., Hurlow A; Palliative Care, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Mayland C; Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., O'Dwyer J; Academic Unit of Health Economics, University of Leeds Leeds Institute of Health Sciences, Leeds, UK., Pini S; Psychological and Social Medicine, University of Leeds, Leeds, UK., Swinson D; Leeds Cancer Centre, St James's University Hospital, Leeds, UK., Richards SH; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Mulvey MR; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. |
